SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 140 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2013. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $203,273 | -98.2% | 1,775 | -98.8% | 0.01% | -99.2% |
Q3 2019 | $11,219,000 | +183.0% | 148,947 | +396.5% | 0.84% | +310.7% |
Q2 2018 | $3,965,000 | +22.3% | 30,000 | -31.5% | 0.20% | +48.6% |
Q1 2018 | $3,243,000 | -12.9% | 43,767 | -34.6% | 0.14% | -29.2% |
Q4 2017 | $3,722,000 | -45.3% | 66,891 | -55.4% | 0.20% | -43.1% |
Q3 2017 | $6,805,000 | +134.4% | 150,023 | +74.2% | 0.34% | +118.5% |
Q2 2017 | $2,903,000 | -13.6% | 86,100 | -24.1% | 0.16% | -5.4% |
Q1 2017 | $3,360,000 | -60.2% | 113,500 | -63.1% | 0.17% | -70.3% |
Q4 2016 | $8,432,000 | +3034.6% | 307,400 | +6926.3% | 0.56% | +3620.0% |
Q3 2016 | $269,000 | -95.8% | 4,375 | -98.7% | 0.02% | -95.5% |
Q2 2016 | $6,459,000 | +41.9% | 338,675 | +138.8% | 0.34% | -13.6% |
Q3 2015 | $4,553,000 | +92.8% | 141,813 | +183.6% | 0.39% | +76.5% |
Q3 2013 | $2,361,000 | -19.9% | 50,000 | -35.5% | 0.22% | -26.6% |
Q2 2013 | $2,948,000 | – | 77,500 | – | 0.30% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |